U.S. Wealth WatcherCelebrating Political Fortunes
‹ Lobbying

TRIS PHARMA, INC. AND ITS WHOLLY OWNED SUBSIDIARY ADNEURIS THERAPEUTICS FKA TRIS

NJ · 4 filings, 2025

Lobbying spend · 2025
$200K
to shape legislation

1Lobbies on

2Through these firms · 1

AEGIS LLC